Transarterial chemoembolization (TACE) in patients with unresectable diffuse vs. focal hepatocellular carcinoma (HCC).

被引：1
|
作者：
Pan, SH [1 ]
Ramirez, C [1 ]
Hoffman, A [1 ]
Sher, L [1 ]
Rojter, S [1 ]
Lopez, RR [1 ]
机构：
[1] St Vincents Med Ctr, Los Angeles, CA USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)86110-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1136
引用
收藏
页码：A991 / A991
页数：1
相关论文
共 50 条
  • [11] Transarterial Chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis -: Experiences
    Herber, S.
    Pitton, M.
    Moench, C.
    Schneider, J.
    Manzl, N.
    Kummer, I.
    Kanzler, S.
    Schuchmann, M.
    Junginger, T.
    Dueber, C.
    Otto, G.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (04): : 306 - 315
  • [12] Transarterial chemoembolization (TACE) for unresectable HCC: A new life begins?
    Biolato, M.
    Marrone, G.
    Racco, S.
    Di Stasi, C.
    Miele, L.
    Gasbarrini, G.
    Landolfi, R.
    Grieco, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 356 - 362
  • [13] The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
    Popa, Bogdan Valeriu
    Bratu, Ana Magdalena
    Minoiu, Costin Aurelian
    Turculet, Claudiu
    Ene, Dragos
    Constantinescu, Gabriel
    Ilie, Madalina
    Popescu, Mina
    Badila, Elisabeta
    REVISTA DE CHIMIE, 2015, 66 (03): : 408 - 412
  • [14] Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): No need for antibiotic prophylaxis.
    Andriulli, A
    Modola, G
    Lezzi, G
    Siena, D
    Conoscitore, P
    Nardella, G
    Facciorusso, D
    Mangia, A
    Giacobbe, A
    GASTROENTEROLOGY, 1997, 112 (04) : A532 - A532
  • [15] Hepatocellular carcinoma (HCC): ART-score and retreatment with transarterial chemoembolization (TACE)
    Dionisio de Sousa, I. J.
    Rodrigues, J.
    Pais, A.
    Bonito, N.
    Jacinto, P.
    Marques, M.
    Ribeiro, J.
    Figueiredo, P.
    Gervasio, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S420 - S421
  • [16] Trial Results for Sunitinib and Transarterial Chemoembolization (TACE) in Inoperable Hepatocellular Carcinoma (HCC)
    Wu, Y. V.
    Tomaszewski, G. M.
    Fetterly, G. J.
    Kuvshinoff, B.
    Groman, A.
    Wilkinson, N. W.
    Khushalani, N. I.
    Iyer, R. V.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S114 - S115
  • [17] FACTORS AFFECTING OUTCOMES AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR HEPATOCELLULAR CARCINOMA (HCC)
    Suman, A.
    Sharma, A.
    Venkataperumal, S.
    Limaye, A.
    Morelli, G.
    Clark, V.
    Soldevila-Pico, C.
    Cabrera, R.
    Firpi, R.
    Nelson, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S395 - S395
  • [18] Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Jie Wu
    Lei Song
    Dan-Yi Zhao
    Bing Guo
    Jing Liu
    World Journal of Gastroenterology, 2014, (31) : 10960 - 10968
  • [19] Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Wu, Jie
    Song, Lei
    Zhao, Dan-Yi
    Guo, Bing
    Liu, Jing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10960 - 10968
  • [20] Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta-analysis
    Li, Yong
    Liu, Xingyu
    Liu, Junning
    Yang, Linfeng
    Wei, Song
    Li, Jijiang
    Gan, Huixin
    Ma, Ting
    Yi, Pengsheng
    ONCOLOGY LETTERS, 2024, 28 (02)
12345